{"count": 59, "results": [{"_id": "36284992", "pmid": 36284992, "pmcid": "PMC9588327", "title": "The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation", "journal": "Dis Markers", "authors": ["Fu J", "Wang T", "Li B", "Zhao N"], "date": "2022-10-15T00:00:00Z", "doi": "10.1155/2022/1111438", "meta_date_publication": "2022", "meta_volume": "2022", "meta_issue": "", "meta_pages": "1111438", "score": 50279.258, "text_hl": "The Efficacy of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Aspirin@@@ in the Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@Coronary Heart Disease@@@ and Its Effect on Platelet Aggregation", "citations": {"NLM": "Fu J, Wang T, Li B, Zhao N. The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation Dis Markers. 2022;2022():1111438. PMID: 36284992", "BibTeX": "@article{36284992, title={The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation}, author={Fu J and Wang T and Li B and Zhao N}, journal={Dis Markers}, volume={2022}, pages={1111438}}"}}, {"_id": "33152659", "pmid": 33152659, "title": "Postmortem fatal and non-fatal concentrations of amlodipine.", "journal": "Forensic Sci Int", "authors": ["Alvarez JC", "Mayer-Duverneuil C", "Cappy J", "Lorin de la Grandamison G", "Knapp-Gisclon A"], "date": "2020-11-01T00:00:00Z", "doi": "10.1016/j.forsciint.2020.110555", "meta_date_publication": "2020 Nov", "meta_volume": "316", "meta_issue": "", "meta_pages": "110555", "score": 50264.633, "text_hl": "...@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ is a @CHEMICAL_1_4_dihydropyridine @CHEMICAL_MESH:C038806 @@@dihydropyridine@@@ calcium channel blocker widely used in the treatment of high blood @DISEASE_Pressure_Ulcer @DISEASE_MESH:D003668 @@@pressure@@@ and @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@. ", "citations": {"NLM": "Alvarez JC, Mayer-Duverneuil C, Cappy J, Lorin de la Grandamison G, Knapp-Gisclon A. Postmortem fatal and non-fatal concentrations of amlodipine. Forensic Sci Int. 2020 Nov;316():110555. PMID: 33152659", "BibTeX": "@article{33152659, title={Postmortem fatal and non-fatal concentrations of amlodipine.}, author={Alvarez JC and Mayer-Duverneuil C and Cappy J and Lorin de la Grandamison G and Knapp-Gisclon A}, journal={Forensic Sci Int}, volume={316}, pages={110555}}"}}, {"_id": "31556335", "pmid": 31556335, "title": "Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism.", "journal": "Xenobiotica", "authors": ["Yang J", "Li Y", "Li Y", "Rui X", "Du M", "Wang Z"], "date": "2020-06-01T00:00:00Z", "doi": "10.1080/00498254.2019.1673918", "meta_date_publication": "2020 Jun", "meta_volume": "50", "meta_issue": "6", "meta_pages": "685-688", "score": 50258.734, "text_hl": "@CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@Atorvastatin@@@ combined with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ (@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@ALDP@@@) can efficiently treat the @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@. ", "citations": {"NLM": "Yang J, Li Y, Li Y, Rui X, Du M, Wang Z. Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism. Xenobiotica. 2020 Jun;50(6):685-688. PMID: 31556335", "BibTeX": "@article{31556335, title={Effects of atorvastatin on pharmacokinetics of amlodipine in rats and its potential mechanism.}, author={Yang J and Li Y and Li Y and Rui X and Du M and Wang Z}, journal={Xenobiotica}, volume={50}, number={6}, pages={685-688}}"}}, {"_id": "37387757", "pmid": 37387757, "pmcid": "PMC10307455", "title": "Retracted: The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation", "journal": "Dis Markers", "authors": ["Markers D"], "date": "2023-06-21T00:00:00Z", "doi": "10.1155/2023/9845626", "meta_date_publication": "2023", "meta_volume": "2023", "meta_issue": "", "meta_pages": "9845626", "score": 50257.574, "text_hl": "Retracted: The Efficacy of @CHEMICAL_Rosuvastatin_Calcium @CHEMICAL_MESH:D000068718 @@@Rosuvastatin@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@, and @CHEMICAL_Aspirin @CHEMICAL_MESH:D001241 @@@Aspirin@@@ in the Treatment of @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@Hypertension@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@Coronary Heart Disease@@@ and Its Effect on Platelet Aggregation", "citations": {"NLM": "Markers D. Retracted: The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation Dis Markers. 2023;2023():9845626. PMID: 37387757", "BibTeX": "@article{37387757, title={Retracted: The Efficacy of Rosuvastatin, Amlodipine, and Aspirin in the Treatment of Hypertension with Coronary Heart Disease and Its Effect on Platelet Aggregation}, author={Markers D}, journal={Dis Markers}, volume={2023}, pages={9845626}}"}}, {"_id": "35932912", "pmid": 35932912, "title": "Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.", "journal": "Am Heart J", "authors": ["Wang SY", "Hanna JM", "Gongal P", "Onuma OK", "Nanna MG"], "date": "2022-12-01T00:00:00Z", "doi": "10.1016/j.ahj.2022.07.006", "meta_date_publication": "2022 Dec", "meta_volume": "254", "meta_issue": "", "meta_pages": "30-34", "score": 50243.977, "text_hl": "We compared the use of @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, or @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on the primary outcome of combined @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@, @DISEASE_Stroke @DISEASE_MESH:D020521 @@@stroke@@@, or all-cause mortality in @SPECIES_9606 @@@patients@@@ with isolated @DISEASE_Isolated_Systolic_Hypertension @DISEASE_MESH:D000092244 @@@systolic hypertension@@@ or isolated @DISEASE_Hypertension_Diastolic_Resistance_to @DISEASE_MESH:C563897 @@@diastolic hypertension@@@.", "citations": {"NLM": "Wang SY, Hanna JM, Gongal P, Onuma OK, Nanna MG. Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial. Am Heart J. 2022 Dec;254():30-34. PMID: 35932912", "BibTeX": "@article{35932912, title={Choice of antihypertensive agent in isolated systolic hypertension and isolated diastolic hypertension: A secondary analysis of the ALLHAT trial.}, author={Wang SY and Hanna JM and Gongal P and Onuma OK and Nanna MG}, journal={Am Heart J}, volume={254}, pages={30-34}}"}}, {"_id": "31977576", "pmid": 31977576, "title": "The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.", "journal": "J Hypertens", "authors": ["Juraschek SP", "Simpson LM", "Davis BR", "Shmerling RH", "Beach JL", "Ishak A", "Mukamal KJ"], "date": "2020-05-01T00:00:00Z", "doi": "10.1097/HJH.0000000000002359", "meta_date_publication": "2020 May", "meta_volume": "38", "meta_issue": "5", "meta_pages": "954-960", "score": 50239.74, "text_hl": "METHODS: The Antihypertensive and @CHEMICAL_Lipids @CHEMICAL_MESH:D008055 @@@Lipid@@@-Lowering Treatment to Prevent @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@Heart Attack@@@ Trial (ALLHAT) was a randomized clinical trial on the effects of first-step @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertension@@@ therapy with @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@, @CHEMICAL_Chlorthalidone @CHEMICAL_MESH:D002752 @@@chlorthalidone@@@, or @CHEMICAL_Lisinopril @CHEMICAL_MESH:D017706 @@@lisinopril@@@ on fatal @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ or nonfatal @DISEASE_Myocardial_Infarction @DISEASE_MESH:D009203 @@@myocardial infarction@@@ (1994-2002). ", "citations": {"NLM": "Juraschek SP, Simpson LM, Davis BR, Shmerling RH, Beach JL, Ishak A, Mukamal KJ. The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. J Hypertens. 2020 May;38(5):954-960. PMID: 31977576", "BibTeX": "@article{31977576, title={The effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.}, author={Juraschek SP and Simpson LM and Davis BR and Shmerling RH and Beach JL and Ishak A and Mukamal KJ}, journal={J Hypertens}, volume={38}, number={5}, pages={954-960}}"}}, {"_id": "20730272", "pmid": 20730272, "title": "Amlodipine and enalapril in coronary disease.", "journal": "Arq Bras Cardiol", "authors": ["Rosa EM", "Fedrizzi el Andari C", "Spagnól MF"], "date": "2010-03-01T00:00:00Z", "doi": "10.1590/s0066-782x2010000300022", "meta_date_publication": "2010 Mar", "meta_volume": "94", "meta_issue": "3", "meta_pages": "403; author reply 404, 427; author reply 428", "score": 50082.977, "text_hl": "@<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@Amlodipine@@@ and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ in @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary disease@@@.", "citations": {"NLM": "Rosa EM, Fedrizzi el Andari C, Spagnól MF. Amlodipine and enalapril in coronary disease. Arq Bras Cardiol. 2010 Mar;94(3):403; author reply 404, 427; author reply 428. PMID: 20730272", "BibTeX": "@article{20730272, title={Amlodipine and enalapril in coronary disease.}, author={Rosa EM and Fedrizzi el Andari C and Spagnól MF}, journal={Arq Bras Cardiol}, volume={94}, number={3}, pages={403; author reply 404, 427; author reply 428}}"}}, {"_id": "10932029", "pmid": 10932029, "title": "Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT.", "journal": "Can J Cardiol", "authors": ["Mancini GB"], "date": "2000-07-01T00:00:00Z", "meta_date_publication": "2000 Jul", "meta_volume": "16 Suppl D", "meta_issue": "", "meta_pages": "5D-7D", "score": 50074.867, "text_hl": "The antiatherosclerotic effects were discordant in that minor @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary lesions@@@ were not affected, whereas carotid intima-media thickness showed significantly less progression in the @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@-treated @SPECIES_9606 @@@patients@@@. ", "citations": {"NLM": "Mancini GB. Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT. Can J Cardiol. 2000 Jul;16 Suppl D():5D-7D. PMID: 10932029", "BibTeX": "@article{10932029, title={Overview of the prospective randomized evaluation of the vascular effects of Norvasc (amlodipine) trial: PREVENT.}, author={Mancini GB}, journal={Can J Cardiol}, volume={16 Suppl D}, pages={5D-7D}}"}}, {"_id": "19390704", "pmid": 19390704, "title": "Combination of amlodipine and enalapril in hypertensive patients with coronary disease.", "journal": "Arq Bras Cardiol", "authors": ["Rienzo M", "Saraiva JF", "Nogueira PR", "Gomes EP", "Moretti MA", "Ferreira JF", "Armagnajian D", "Mansur Ade P", "Ramires JA", "César LA"], "date": "2009-03-01T00:00:00Z", "doi": "10.1590/s0066-782x2009000300004", "meta_date_publication": "2009 Mar", "meta_volume": "92", "meta_issue": "3", "meta_pages": "173-9, 177-83", "score": 50068.426, "text_hl": "Combination of @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@ and @CHEMICAL_Enalapril @CHEMICAL_MESH:D004656 @@@enalapril@@@ in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ with @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary disease@@@.", "citations": {"NLM": "Rienzo M, Saraiva JF, Nogueira PR, Gomes EP, Moretti MA, Ferreira JF, Armagnajian D, Mansur Ade P, Ramires JA, César LA. Combination of amlodipine and enalapril in hypertensive patients with coronary disease. Arq Bras Cardiol. 2009 Mar;92(3):173-9, 177-83. PMID: 19390704", "BibTeX": "@article{19390704, title={Combination of amlodipine and enalapril in hypertensive patients with coronary disease.}, author={Rienzo M and Saraiva JF and Nogueira PR and Gomes EP and Moretti MA and Ferreira JF and Armagnajian D and Mansur Ade P and Ramires JA and César LA}, journal={Arq Bras Cardiol}, volume={92}, number={3}, pages={173-9, 177-83}}"}}, {"_id": "19232755", "pmid": 19232755, "title": "Coronary heart disease benefits from blood pressure and lipid-lowering.", "journal": "Int J Cardiol", "authors": ["Sever PS", "Poulter NR", "Mastorantonakis S", "Chang CL", "Dahlof B", "Wedel H", "ASCOT Investigators"], "date": "2009-06-26T00:00:00Z", "doi": "10.1016/j.ijcard.2009.01.036", "meta_date_publication": "2009 Jun 26", "meta_volume": "135", "meta_issue": "2", "meta_pages": "218-22", "score": 50066.633, "text_hl": "BACKGROUND: We have reported the benefits of @CHEMICAL_Atorvastatin @CHEMICAL_MESH:D000069059 @@@atorvastatin@@@ and of an @<m>CHEMICAL_Amlodipine</m> @CHEMICAL_MESH:D017311 @@@amlodipine@@@-based regimen on @<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@coronary heart disease@@@ (@<m>DISEASE_Coronary_Disease</m> @DISEASE_MESH:D003327 @@@CHD@@@) events in @DISEASE_Hypertension @DISEASE_MESH:D006973 @@@hypertensive@@@ @SPECIES_9606 @@@patients@@@ in the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT). ", "citations": {"NLM": "Sever PS, Poulter NR, Mastorantonakis S, Chang CL, Dahlof B, Wedel H, ASCOT Investigators. Coronary heart disease benefits from blood pressure and lipid-lowering. Int J Cardiol. 2009 Jun 26;135(2):218-22. PMID: 19232755", "BibTeX": "@article{19232755, title={Coronary heart disease benefits from blood pressure and lipid-lowering.}, author={Sever PS and Poulter NR and Mastorantonakis S and Chang CL and Dahlof B and Wedel H and ASCOT Investigators}, journal={Int J Cardiol}, volume={135}, number={2}, pages={218-22}}"}}]}